Transferring Care to Enhance Access to Early-phase Cancer Clinical Trials - Stand Up To Cancer

Research Teams

Research  >  Research Portfolio  >  Research Teams  >  Transferring Care to Enhance Access to Early-phase Cancer Clinical Trials

Increasing Diversity in Cancer Clinical Trials: Transferring Care to Enhance Access to Early-phase Cancer Clinical Trials

Grant Term: TBD

The Diversity in Early Development Clinical Trials Research Grants Program is supporting four teams to increase diversity among participants in Phase 1 and Phase 2 cancer clinical trials. The objective is to increase accessibility for patients of all racial and ethnic backgrounds and/or medically underserved locations
to equally participate in studies.

Each Team is bringing together key stakeholders that are deeply connected to the impacted communities, integrating social/ behavioral determinants of health, community engagement and outreach with cancer biology, prevention, and treatment, and realizing the ideal of health equity.

Supported by:

ABOUT THIS TEAM’S RESEARCH

Pediatric New Therapies Challenge Overview

MEET THE TEAM

TEAM MEMBERS

David Gerber, MD
UT Southwestern
Leader

Chika Nwachukwu, MD, PhD
UT Southwestern
Co-leader

TEAM PROGRESS UPDATES

Stand Up To Cancer’s research projects are designed to foster collaborative, swift translational research. The hallmarks of these efforts include rigorous application and selection procedures, sufficient funding to allow scientists to focus on the objectives of the grant, and reviews by senior scientists every six months. These reviews help the investigators capitalize on the latest findings, address potential roadblocks, and collaboratively evolve as the science requires. Please click on the link to see summaries of research results so far for the Transferring Care to Enhance Access to Early-phase Cancer Clinical Trials team.

TEAM PROGRESS UPDATES

PUBLICATIONS

Links to publications will be posted when they are available.

CANCER CLINICAL TRIALS REFERRALS

Cancer clinical trials allow researchers to study innovative and potentially life-saving new treatments. The goal is to find treatments that are better than what’s currently available; in fact, the therapies offered to today’s cancer patients were almost all studied and made possible by people participating in clinical trials. But many cancer clinical trials aren’t completed because not enough people take part.

At StandUpToCancer.org/ClinicalTrials, you’ll find clinical trial information, answers to common questions, and a free clinical trial finder tool.

LEARN MORE

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.